psychiatric aspects of adolescent co-occurring disorders
DESCRIPTION
Psychiatric Aspects of Adolescent Co-occurring Disorders. Seth Eisenberg MD Medical Director, DHS-DASA October 24, 2011. Eisenberg Outline. Similarities and relationships between AOD and psych symptoms Mental Status Exam, Diagnosis and Psychiatric Symptoms Anxiety Disorders - PowerPoint PPT PresentationTRANSCRIPT
1
Psychiatric Aspects of Adolescent Psychiatric Aspects of Adolescent Co-occurring Disorders Co-occurring Disorders
Seth Eisenberg MDMedical Director, DHS-DASA
October 24, 2011
2
Eisenberg OutlineEisenberg Outline
Similarities and relationships between AOD and psych symptoms
Mental Status Exam, Diagnosis and Psychiatric Symptoms
Anxiety Disorders Elements of Medication Treatment Adolescent Gambling Ask the Doc
3
AOD Use and Psychiatric Symptoms
AOD use can cause psychiatric symptoms and mimic psychiatric syndromes.
AOD use can initiate or exacerbate a psychiatric disorder.
AOD use can mask psychiatric symptoms and syndromes.
AOD withdrawal can cause psychiatric symptoms and mimic psychiatric syndromes.
Psychiatric and substance use disorders can independently coexist.
Psychiatric behaviors can mimic substance use problems.SAMHSA TIP #9
SAMHSA TIP #9
4
Drugs That Precipitate or Mimic Mood Disorders
Mood DisordersDuring Use
(Intoxication)After Use
(Withdrawal)Depressionand dysthymia
Alcohol,benzodiazepines,opioids, barbiturates,cannabis, steroids(chronic), stimulants(chronic)
Alcohol,benzodiazepines,barbiturates, opiates,steroids (chronic),stimulants (chronic)
Mania andcylothymia
Stimulants, alcohol,hallucinogens,inhalants (organicsolvents), steroids(chronic, acute)
Alcohol,benzodiazepines,barbiturates, opiates,steroids (chronic),
SAMHSA TIP #9
5
Adolescent DependencyAdolescent Dependency
GENERAL EFFECTS
The adolescent demonstrating these behaviors maybe indicating a problem with drugs and/or alcohol:
Sudden, noticeable personality changes Severe mood swings Changing peer groups Dropping out of extra-curricular activities
ADOL-CD Cont’d
6
GENERAL EFFECTSGENERAL EFFECTS
Decreased interest in leisure time activities Worsening grades Irresponsible attitude toward household
jobs and curfews Depressed feelings much of the time Dramatic change in personal hygiene
concern Changes in sleeping or eating habits
ADOL-CD Cont’d
7
GENERAL EFFECTSGENERAL EFFECTS
Smell of alcohol or pot Sudden weight loss Tendency toward increasing dishonesty Trouble with the law Truancy from school
ADOL-CD Cont’d
8
Frequent job losses or changes Turned off attitude if drugs are discussed Missing household money or objects Increasing time alone in his/her room
ADOL-CD Cont’d
GENERAL EFFECTSGENERAL EFFECTS
9
Deteriorating family relationships Drug use paraphernalia, booze, or empty
bottles found hidden Observations of negative behavior by
people within or outside immediate family Obvious signs of physical intoxication
ADOL-CD Cont’d
GENERAL EFFECTSGENERAL EFFECTS
10
Some of these behaviors are a sign of typical adolescent development, BUT,
a wide variety of them in one person should raise suspicions of the likelihood of harmful involvement with drugs or alcohol….
OR—some kind of psychiatric problem
ADOL-CD Cont’d
GENERAL EFFECTSGENERAL EFFECTS
11
Adolescent Comorbidity
The syndrome most consistently associated with substance use is
delinquent behavior,
followed by scales measuring social problems and attention problems
12
The likelihood of substance use among adolescents is associated with the severity of emotional and behavioral problems across age and gender groups.
Adolescent Comorbidity
13
Past-month marijuana use was nearly 2x as likely and use of other drugs was 4x more likely for adolescents with serious emotional problems than for adolescents with low levels of emotional problems.
Adolescent Comorbidity
14
Past-month marijuana use was 4x as likely, and use of other drugs was nearly 7x more likely, for adolescents with serious behavioral problems than for adolescents with low levels of behavioral problems.
Adolescent Comorbidity
15
Dependence on substances such as cocaine, crack, inhalants, hallucinogens, heroin or prescription drugs was nearly 9x as likely among adolescents with serious behavioral problems.
Adolescent Comorbidity
16
Past-month alcohol use was nearly 2x as likely for adolescents with serious emotional problems than for adolescents with low levels of emotional problems.
Adolescent Comorbidity
17
Adolescents with serious behavioral problems were nearly 3x as likely to use alcohol in the past month than adolescents with low levels of behavioral problems
Adolescent Comorbidity
18
Adolescents with serious emotional problems were nearly 4x more likely to be dependent on alcohol or illicit drugs than adolescents with low levels of emotional problems.
Adolescent Comorbidity
19
Alcohol or drug dependence was more likely among adolescents with serious behavioral problems than among adolescents with low levels of behavioral problems
Adolescent Comorbidity
20
Stealing, swearing, hanging around with troublemakers and running away from home -
Feeling confused or in a fog
were associated with more substance use
Adolescent Comorbidity
21
While overall substance use is generally higher for adolescent males than for females, females with high ratings for psychosocial problems as measured by the YSR were as likely as males to smoke cigarettes, binge drink or use illicit drugs.
Adolescent Comorbidity
22
• Juvenile Delinquency• Runaways• High School Dropouts• Youth With Psychiatric Disorders• Unmarried Pregnant Adolescents• Youth That Have Been Physically, Sexually, or Emotionally Abused
Risk Factors
Adolescent Comorbidity
23
• Unsatisfactory Family Relations• Children in Foster Care• Extreme Sexual Activity• Exploited Youth• School Difficulty - Low G.P.A.
Risk Factors
Adolescent Comorbidity
24
• Family Social Deprivation, i.e., Poverty• Association with Delinquent Peers• Neighborhood/Community Disorganization• Affiliation with Peers of Other Dysfunctional Family Systems
Risk Factors
Adolescent Comorbidity
25
• More Impulsive• Less Mature• More Peer Oriented• Restless (tension reduction oriented)
Characteristic Profile
Adolescent Comorbidity
26
• Rebellious• Increased Sadness• Increased Social Withdrawal• Learning Problems
Characteristic Profile
Adolescent Comorbidity
27
Adolescent Chemical DependencyAdolescent Chemical Dependency
Low self esteem Feelings of not belonging Poor coping skills Poor interpersonal skills Poor situational skills, poor judgement Biogenetic factors
ADOL-CD Cont’d
Individual Risk
28
Adolescent ComorbidityWhen Compared to Non-CD Psychiatric Cases
• Earlier First Use of Drugs (14 vs 12)• Increased Divorce (56% vs 26%)• Increased Parental CD• Increased Parental Psychiatric Illness
29
Adolescent ComorbidityWhen Compared to Non-CD Psychiatric Cases
• More Legal Problems• Increased Special Education Placement• More Frequent Suicide Attempts• Increased Residential Placement
30
Adolescent ComorbidityAssociated with:
• Earlier Onset of Abuse Behaviors• Greater Clinical Severity• Poorer Outcomes• Increased Disturbance of Relationships
31
Adolescent ComorbidityAssociated with:
• Differential Responsiveness to CD Treatment• Increased Risk of Relapse• Less than Optimal Functioning when Abstinent
32
Adolescent ComorbidityDiagnostic Considerations
• Impact of Chemical Use decreased withdrawal symptoms varied expression of use negative effect on development
• Emerging Psychiatric Illness usual age of onset precipitating event
33
• Commonality of Symptoms of Psychiatric Disorders
ADHD, bipolar, depression, CD, anxiety
• Confounding Symptoms of Adolescent CD Intoxication Chronic use ABCD-S
Adolescent ComorbidityDiagnostic Considerations
34
Adolescent ComorbidityAdolescent Behavior CD Syndrome
• High Delinquency• Hyperactivity• Decreased School Performance• Decreased Social Competence/Participation• Depressed Behaviors• Onset after development of CD and subsides 2 months after onset of sobriety
35
Adolescent ComorbidityABCD-S (Continued)
• May Result In: developmental dysfunction hyperactivity, distractibility restlessness, impulsivity depression and suicide
• Possible Overdiagnosis of Psychiatric illness
36
Diagnostic DilemmasDiagnostic Dilemmas
Psychoactive substances have profound effects on neurotransmitter systems– Neurotransmitters may be involved in
psychiatric disease states– May unmask genetic vulnerability– May cause a psychiatric disease
It may be difficult to differentiate which diagnosis is primary, ie which “came first”
37
Psychiatric DiagnosisPsychiatric Diagnosis
Mental Status Exam and Psychiatric Symptoms
38
MENTAL STATUS EXAMINATION (MSE)
APPEARANCE
SPEECH
EMOTIONS (mood & affect)
THOUGHT PROCESS
THOUGHT CONTENT
PERCEPTIONS
Formal or MINI MSE
ORIENTATION
MEMORY
CONCENTRATION
INSIGHT
JUDGMENT
IMPULSE CONTROL
39
MENTAL STATUS EXAMINATION (MSE)MENTAL STATUS EXAMINATION (MSE)
Appearance– Physical appearance, mannerisms, attitude
Speech – Rate, rhythm, volume, articulation
Mood– “how do you feel today”
Affect– Outward expression of inner mood: range,
intensity, stability, appropriate
40
MENTAL STATUS EXAMINATION (MSE)MENTAL STATUS EXAMINATION (MSE)
Thought Process– Productivity, continuity, coherence
Thought Content – fears, obsessions, paranoia, suicide, violence
Perceptions– Hallucinations and illusions, depersonalization
Orientation and Cognition (formal MSE)
41
Overview of Psychiatric Disorders Overview of Psychiatric Disorders and Symptomsand Symptoms
Schizophrenia and Psychosis Mood Disorders Anxiety Disorders ADHD and Impulse Control Disorders Personality Disorders Developmental Disorders Sleep Problems
42
Schizophrenia and Schizophrenia and Other Psychotic Disorders Other Psychotic Disorders
Schizophrenia Schizophreniform Schizoaffective Disorder Delusional Disorder Brief Psychotic Disorder Substance Induced Psychotic Disorder
43
Symptoms of PsychosisSymptoms of Psychosis
Hallucinations Delusions (bizarre and non-bizarre) Disorganized speech Disorganized thinking Disorganized behavior or catatonia “negative symptoms”
44
Antipsychotics/NeurolepticsAntipsychotics/NeurolepticsTraditional—First GenerationTraditional—First Generation
chlorpromazine fluphenazine haloperidol perphenaxzine thioridazine thiothixene trifluoperazine
Thorazine, Prolixin, Haldol (decanoate), Trilafon, Mellaril, Navane, Stelazine
45
Antipsychotics/NeurolepticsAntipsychotics/NeurolepticsAtypical, Novel—Second GenerationAtypical, Novel—Second Generation
aripiprazole clozapine olanzapine quetiapine risperidone ziprasidone
Abilify, Clozaril, Zyprexa (zydis), Seroquel, Risperdal Geodon, Saphris, Fanapt, Latuda
• Consta• Invega Sustena• Relprev
46
Mood DisordersMood Disorders
Depressive Disorders– Major Depressive Disorder– Dysthymic Disorder
BiPolar Disorders– Bipolar I– Bipolar II
Cyclothymic Disorder Substance Induced Mood Disorder
47
Symptoms of DepressionSymptoms of Depression
Depressed mood, sadness, crying Decreased interest and pleasure Decreased energy and activity Weight change, sleep change Low self esteem, worthlessness, guilt Decreased concentration Suicidal ideation
48
ADOLESCENT COMORBIDITYDepression
•Mostly studied - high prevalence in adults•Approximately 80% clear in two weeks•In adolescents - frequent suicidality•Suicide attempts with increased medical seriousness and lethality•Family history important•Developmental history important
49
AAntidepressantsntidepressantsSSRIsSSRIs
citalopram escitalopram fluoxetine fluvoxamine paroxetine setraline
Celexa, Lexapro, Prozac, Prozac weekly, Sarafem
Luvox, Paxil, Paxil CR, Zoloft
Cymbalta, Pristiq, Paxeva
50
AAntidepressantsntidepressantsTricyclicsTricyclics
amitriptyline clomipramine desipramine doxipin imipramine maprotiline nortriptyline protriptyline
Elavil, Anafranil, Norpramin, Sinequan, Tofranil, Ludiomil, Pamelor, Vivactil
51
AAntidepressantsntidepressantsOthersOthers
buproprion mirtazapine trazadone venlafaxline isocarboxazide phenelzine tranylcypromine
Wellbutrin (SR, XL), Remeron, Deseryl, Effexor (ER), Marplan, Nardil, Parnate
52
Symptoms of Bipolar ManiaSymptoms of Bipolar Mania Elevated, expansive mood of well being More irritable or agitated Grandiose delusions Decreased need for sleep More talkative than usual Racing thoughts More action and activity Increased distractibility
53
Antimanic MedicationsAntimanic Medications
lithium carbamazepine divalproex sodium gabapentin lamotrigine oxcarbazepine TopiramateAtypical Antipsychotics
Eskalith, Tegratol, Depakote, Neurontin, Lamictal, Trileptal, Topamax
54
Anxiety DisordersAnxiety Disorders
What is Anxiety?
55
Symptoms of Anxiety
autonomic hyperactivity increased hand tremor insomnia nausea or vomiting psychomotor agitation AnxietyNervous, tense, fearful and high strung
56
Symptoms of AnxietySymptoms of Anxiety
Panic attacks and fear of panic attacks Excessive worry about everything Intrusive memories, flashbacks, fears Excessive anxiety in social situations—fear of
negative judgment and embarrassment Repeating thoughts or behaviors
57
Anxiety DisordersAnxiety Disorders
Panic Disorder--with agoraphobia Social Phobia Generalized Anxiety Disorder Obsessive-Compulsive Disorder Acute Stress Disorder Posttraumatic Stress Disorder Substance-Induced Anxiety Disorder
58
Panic AttackPanic Attack Palpitations, pounding, chest pain/discomfort Sweating Trembling or shaking SOB Feeling of choking Nausea or abdominal distress Dizzy, unsteady, lightheaded or faint Derealization, depersonalization Fear of losing control, going crazy, dying
59
AgoraphobiaAgoraphobia Anxiety about being in places or situations from
which escape might be difficult (or embarrassing) in the event of a panic attack
The situations are avoided or are endured with marked distress
Anxiety or phobic avoidance is not better accounted for by another mental disorder
60
Social PhobiaSocial Phobia Marked and persistent fear of social or performance
situations, possible scrutiny by others or may act in a way that will be embarrassing or humiliating
Exposure to feared social situation provokes anxiety (or may have panic attack)
Person recognizes that the fear is excessive Feared situations are avoided or endured Avoidance, anxious anticipation or distress interferes
with functioning
61
Social Phobia“Marked and persistent fear of social or performance situations in which embarrassment may occur” (DSM
IV)
Prevalence 12% to 56% in alcoholic populations
May interfere with treatment
Specific symptoms for diagnosis
SSRIs (delayed effect)
62
Generalized Anxiety DisorderGeneralized Anxiety Disorder Excessive anxiety and worry (apprehensive
expectation) about number of events occurring more days than not
Difficult to control the worry Associated with three or more frequently present
– Restlessness or feeling keyed up, on edge– Easily fatigued, – Irritability– difficulty concentrating or mind going blank– Muscle tension– Sleep disturbance
63
Obsessive-Compulsive Disorder Obsessive-Compulsive Disorder
Obsessions Recurrent persistent thoughts, impulses or
images—intrusive and inappropriate and cause anxiety or distress
Not simply excessive worries Person attempts to ignore or suppress or
neutralize Recognized as a product of own mind
64
Obsessive-Compulsive DisorderObsessive-Compulsive DisorderCompulsions Repetitive behaviors or mental acts the person feels
driven to perform in response to obsession or according to certain rules
The behaviors or mental acts are aimed a preventing or reducing distress or preventing some dreaded act (not realistic)
At some point are recognized as excessilve or unreasonable
Cause marked distress or are time consuming or significantly interfere
65
Acute Stress DisorderAcute Stress Disorder Exposed to traumatic event with serious threat
and feelings of intense fear, helplessness or horror
During or after event had three or more:– Numbing, detachment or lack of emotions– Reduction in awareness of surroundings– Derealization– Depersonalization – Dissociative amnesia
66
Acute Stress DisorderAcute Stress Disorder Traumatic event is re experienced with
images, thoughts, dreams, flashbacks, reliving or distress with reminders
Marked avoidance of stimuli that remind Marked symptoms of anxiety or increased
arousal (poor sleep, irritable, startle, etc) Causes significant distress or impairment Lasts a minimum of 2 days and maximum of 4
weeks and occurs w/in 4 weeks
67
Post-Traumatic Stress Disorder
“Development of symptoms following exposure to an extreme traumatic stressor” (DSM IV)
30% to 50% prevalence in SUD treatment seekers Goal to reduce key symptoms Target symptom constellations
TCAs and MAOI’s - Depressive and intrusive
Neuroleptics - Psychosis and dissociation Carbamazipine - Impulse dyscontrol Clonidine, Beta Blockers, Benzos -
arousal SSRIs
68
ADOLESCENT COMORBIDITYPTSD
•Child/adolescent sexual and physical abuse•Increased depression, anxiety, negative self concept, suicidal behavior•Adolescent antisocial behavior
69
ADOLESCENT COMORBIDITYPTSD
•Increased school problems, run away, placement, legal difficulties•More drugs with more frequent use•Motivation for substance use
reduce tension sleep relieve pain or discomfort escape family problems
70
Antianxiety MedicationsAntianxiety Medications alprazolam chlordiazepoxide clonazepam diazepam lorazepam oxazepam buspirone propranolol hydroxyzine
Xanex, Librium, Klonopin, Valium, Ativan, Serax, Buspar, Inderal, Atarax (Vistaril)
SSRIsAtypicals
71
Anxiety Disorders and SUDAnxiety Disorders and SUDMedication TreatmentMedication Treatment
Panic Disorder (5-42% in AUD, 7-13% in MMT) SSRI, TCA, MAOI, benzodiazepines all effective
(not studied in COD populations) May have initial activation with SSRI and TCA
that could increase risk of relapse—use low dose initiation
Latency of onset of effect, 2-6 weeks SSRIs—no abuse potential, safe, generally well
tolerated, may help with ETOH
72
Anxiety Disorders and SUDAnxiety Disorders and SUDMedication TreatmentMedication Treatment
Benzos usually avoided in SUD populations (but not an absolute contraindication)
Panic disorder can also be treated with anticonvulsants (valproate or carbamazepine) and Panic with stimulant abuse may respond to these agents due to neuronal sensitization and limbic excitability
TCAs carry risk of lower seizure threshold and interactions with ETOH, depressants and stimulants
73
Anxiety Disorders and SUDAnxiety Disorders and SUDMedication TreatmentMedication Treatment
Social Anxiety Disorder (8-56% in AUD, 14% in cocaine, 6% in MMT)
In most cases SAD precedes AUD so a period of abstinence not so important
Early identification important with COD as SAD may interfere with SUD treatment
SSRI have FDA indication (paroxetine) and may also reduce alcohol use
Venlafaxine and gabapentin
74
Anxiety Disorders and SUDAnxiety Disorders and SUDMedication TreatmentMedication Treatment
Generalized Anxiety Disorder (8-52% in AUD, 21% in MMT, 8% in cocaine)
Diagnostic difficulties—overlap with symptoms of acute intoxication with stimulants and withdrawal from alcohol and sedatives (and anxiety in early recovery--PAWS)
SSRI, TCA, venlafaxine, anticonvulsants Use of benzodiazepines is controversial Buspirone may be effective
75
Comorbid Anxiety and Alcohol Comorbid Anxiety and Alcohol Which Comes First? Which Comes First?
Risk of getting new ETOH Dep as a Jr/Sr more than tripled among students with anxiety dx as a freshman.
Students with ETOH Dep as freshman were 4xmore likely to dev. an anxiety d/o (6yrs)
So having either an anxiety or ETOH d/o earlier in life apears to increase the probability of developing the other later
76
Comorbid Anxiety and Alcohol Comorbid Anxiety and Alcohol Comorbidity ModelsComorbidity Models
1. Having an anxiety disorder predisposes one to develop an SUD via self medication
– “anxiety induced” substance use disorder2. The social, occupational and physiologic
effects of substance use can generate new anxiety symptoms in vulnerables
– Not the same as “substance induced”3. Third factor can serve as a common cause for
both conditions (underlying genetic or physiologic liability)
77
ADHDADHD
Hyperactivity and inattention– Impulsive, overactive, impatient, intrusive– Distracted, poor concentration, procrastinates,
disorganized and forgetful
78
ADOLESCENT COMORBIDITYAttention Deficit/Hyperactivity Disorder
•Differential Diagnosis - bipolar LD Mood and anxiety ABCD-S
•Psychiatric Cormorbidity•Multiple Risks for Substance Abuse•In Adults
79
ADOLESCENT COMORBIDITYAD/HD - Treatment Considerations
•Require Special Programming•Chronic Experience of Failure•Mood Problems - Self Esteem•Disruptive Behaviors•Learning Problems•Difficult family Situations
80
Stimulant MedicationsStimulant Medicationsand Non-Stimulantsand Non-Stimulants
D-amphetamine L & d-amphetamine Methamphetamine Methylphenidate Pemoline Modafinil Atomoxetine Bupropropion Guanefacine-clonidine
Dexedrine, Adderall, Desoxyn, Ritalin, Concerta, Metadate, Focalin, Cylert, Provigil, Strattera, Wellbutrin, TenexIntuniv
81
Personality DisordersPersonality Disorders Antisocial Personality Disorder Paranoid Personality Disorder Schizoid and Schizotypal PD Borderline Personality Disorder Narcissistic Personality Disorder Avoidant Personality Disorder Dependent Personality Disorder
82
Developmental and Organic Developmental and Organic DisordersDisorders
Mental Retardation and other syndromes Autism and Asperger’s Learning Disabilities Communication Disorders Tic DisordersCognitive impairment from seizures, traumatic
brain injury, medical, drugs and alcohol
83
Medication Treatment of Psychiatric Medication Treatment of Psychiatric and Substance Use Disorders and Substance Use Disorders
Psychotherapeutic Medications: What Every Counselor Should Know
Mid-America Addictions Technology Transfer Center
84
Medication TreatmentMedication TreatmentGeneral PrinciplesGeneral Principles
Pharmacologic effects: Therapeutic—indicated purpose and
desired outcome Detrimental—unwanted side effects (may
interfere with adherence), potential for abuse and addiction
Need a balance between therapeutic and detrimental
85
Medication TreatmentMedication TreatmentGeneral PrinciplesGeneral Principles
Psychoactive Potential: Ability of some medications to cause distinct change in mood or thought and psychomotor effects– Stimulation, sedation, euphoria– Delusions, hallucinations, illusions – Motor acceleration or retardation
All drugs of abuse are psychoactive
86
Medication TreatmentMedication TreatmentGeneral PrinciplesGeneral Principles
Many medications are non-psychoactive (except for mild side effects including sedation or stimulation)
Not considered euphorigenic( although can be misused and abused)
Psychoactive drugs considered high risk for abuse and addiction
Some psychoactive meds have less addiction potential (old antihistimines)
87
Medication TreatmentMedication TreatmentGeneral PrinciplesGeneral Principles
Positive reinforcement—increase the likelihood of repeated use– Amplification of positive symptoms or states– Removal of negative symptoms or conditions– Faster reinforcement, more prone to misuse
Tolerance and Withdrawal– Higher risk for abuse and addiction
More concerns when prescribing to high-risk patients
88
Medication TreatmentMedication TreatmentStepwise Treatment Model Stepwise Treatment Model
Risks/benefits analysis (risk of medication, risk of untreated condition, interactions, potential for therapeutic benefits)
Early and aggressive treatment of severe psychiatric problems
Start with more conservative approach with high risk patients and less severe conditions
89
Medication TreatmentMedication TreatmentStepwise Treatment ModelStepwise Treatment Model
High risk patients with anxiety disorder1. Non-pharmacologic approaches when
possible2. Non-psychoactive medications added next as
adjunctive treatment 3. Psychoactive medications when other
treatments fail
90
Medication TreatmentMedication TreatmentStepwise Treatment ModelStepwise Treatment Model
Non-pharmacologic approaches– Psychotherapy, cognitive and behavioral tx, stress
management skills, medication, exercise biofeedback, acupuncture, education, etc
Use meds with low abuse potential Conservative approach not the same as under-
medicating Different treatments should be complementary,
not competitive
91
Talking to Patients about MedicationsTalking to Patients about Medications
Make an inquiry every few sessions Are their Psych meds. Helpful? How? How many doses or how often do you miss? Acknowledge that taking pills everyday is a
hassle and everybody misses sometimes Did they feel or act different? Or use? Explore connections of MH, meds, use Forget? Or choose not to take it.
92
Medication AdherenceMedication AdherenceComorbid SUD: a Risk for Non-adherence Comorbid SUD: a Risk for Non-adherence
May have conflicted feelings and attitudes about medication
Meds may be sometimes discouraged or thought to be un-needed
See it as a sign of weakness May stop meds during relapse May misused meds
93
Talking to Patients about MedicationsTalking to Patients about Medications
Problem solve strategies to not forget– Use a pill box, help set it up– Keep it where it cannot be missed or avoided– Link med taking with some daily activity– Use an alarm clock set for the time to take– Ask someone to help them take meds
94
Talking to Patients about MedicationsTalking to Patients about Medications Some patients may choose not to take meds
– They have a right to make that choice– Owe it to themselves to make sure their important
health decision is well thought out– Explore-- “I just don’t like pills (or meds)”. – Elicit a reason—never needed it, cured now, don’t
believe in it, means I’m crazy, side effects, afraid, shame, cost, interpersonal, want to be in control, do it on my own, can’t use
– Motivational Interviewing
95
Using an Empathic StyleUsing an Empathic Style
An Empathic Style Communicates respect for and acceptance of
clients and their feelings Encourages a nonjudgmental, collaborative
relationship Allows the clinician to be a supportive and
knowledgeable consultant
96
Using an Empathic StyleUsing an Empathic Style
An Empathic Style Compliments and reinforces the client
whenever possible Listens rather than tells Gently persuades, with the understanding
that the decision to change is the client’s Provides support throughout the recovery
process
97
Motives for AdolescentGambling Behavior
RelaxationEnjoyment, Excitement, EntertainmentAdventure, AttentionOpportunityNegative feelings
98
Why Do Youth Gamble?Why Do Youth Gamble?
Excitement Entertainment Escape Economics Ego
99
Psychiatric ComorbidityPsychiatric ComorbidityEffects of Family GamblingEffects of Family Gambling
May be effected directly or indirectly Impact on kids depends on how disorganized or
dysfunctional the family is to begin with and how much gambling disrupts family routines
Impact is greater if parents are pulled away from their roles as caretakers
Impact on children also related to:– .Age of children– .Underlying personalities and character– .Amount of marital discord
100
Psychiatric ComorbidityPsychiatric ComorbidityEffects of Family GamblingEffects of Family Gambling
Children may feel responsible for things they don’t understand and become anxious and guilt ridden—they may develop certain roles they play in the family
Children may get pulled into deceit and subterfuge by the gambler parent
Experience may ultimately shape the child’s values about money
Children may manifest a wide variety of behaviors and moods at home, at school or in the community
101
Psychiatric ComorbidityPsychiatric Comorbidity
Most consistent finding is depression Themes of guilt, self-punishment Hopelessness, lack of motivation, suicide
and loneliness Self-destructive excessive risk-taking Significant life events before depression 2/3 of life events after gambling Subsets of gamblers
102
Psychiatric ComorbidityPsychiatric ComorbidityDSM-IVDSM-IV
Depression-with high suicidality Bipolar Disorder and Cyclothymia ADHD Personality Disorders (APD, NPD, BPD) General medical conditions with stress Substance use disorders Urge to gamble increases during periods of
stress or depression
103
Psychiatric ComorbidityPsychiatric ComorbidityPsychiatric Typology-Psychiatric Typology-BlaszczynskiBlaszczynski
“Normal” problem gamblers Emotionally disturbed gamblers Biological correlates of gambling
104
Pathological Gambling and Pathological Gambling and Substance AbuseSubstance Abuse
More severe substance abuse history More episodes of overdose More prior AOD treatment Used a greater variety of drugs Greater past use of ETOH, opiates and
solvents Greater history of legal problems
105
Why Harm ReductionWhy Harm Reductionfor Adolescent Gamblingfor Adolescent Gambling
Gambling is a SOCIALLY ACCEPTABLE ACTIVITY
Entertainment Unique: no social barriers Promoted in the home environment
106
Adolescent Chemical DependencyTreatment and Outcomes
•Multidimensional and multidisciplinary•Developmental status - habilitation vs. rehabilitation
•Flexibility - stages of change•Family therapy - family issues•Treatment programs - long term OP vs. short term inpatient
107
Adolescent Chemical DependencyTreatment and Outcomes
•Treatment completion, parental involve- ment and aftercare
•Good social supports, self esteem and coping skills
•Greatest relapse risk during first 3 months (>60%)
•Relapse associated with delinquency, social and peer influence, drug craving, less productive and recreational activities
108
Ask the DocAsk the Doc